Italy banking outlook negative as asset quality slides: Moody's

MILAN Tue Nov 20, 2012 4:45am IST

Stocks

   

MILAN (Reuters) - The outlook for Italy's banking sector remains negative, Moody's said on Monday, citing rapid asset quality deterioration and limited access to market funding.

In a report, Moody's said the operating conditions for the banks were difficult and would remain challenging.

"Moody's expects that the banks' asset quality will continue to deteriorate over the outlook period, from already weak levels," it said.

Bad loans at Italian banks, a major concern for investors, rose by 15.3 percent in September as the euro zone crisis continues to take its toll on the real economy.

Earlier on Monday, central bank sources said the Bank of Italy had told domestic lenders to make adequate provisions for rising bad loans and keep restructuring their operations to cut costs.

"The banks' already modest profitability will also continue to weaken, as loan-loss provisions will increase and continue to absorb a higher portion of banks' moderate pre-provision earnings," Moody's said.

Italy's two biggest banks Intesa Sanpaolo (ISP.MI) and UniCredit (CRDI.MI) set aside a combined 8.4 billion euros ($10.2 billion) in the first nine months of the year in the face of rising bad loans.

Last week, the chief executive of UniCredit said he did not expect bad loans in Italy to improve before mid-2013 due to a deep recession.

Rising non-performing loans have forced Italian banks to cut lending to businesses, crimping profits and exacerbating a credit crunch in the euro zone's third largest economy.

In its report Moody's said euro area-wide pressures would continue to restrict Italian banks' access to market funding.

It also said that while the banks had strengthened their balance sheets, capital levels remained vulnerable and below those of other large European banking systems.

(Reporting by Stephen Jewkes; Editing by Leslie Gevirtz)

Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.

  • Most Popular
  • Most Shared

Culling Plans

REUTERS SHOWCASE

Drug Approval

Drug Approval

Epirus, Ranbaxy win India approval for arthritis drug copy.  Full Article 

Fresh Demand

Fresh Demand

As mining curbs bite, India offers market to glut-hit iron ore.  Full Article 

Root Out 'Bad Apples'

Root Out 'Bad Apples'

RBI chief calls for cleaning up of banking system.  Full Article 

Android One

Android One

Google launches $105 Android One; eyes low-price smartphone boom.  Full Article 

Cognizant Deal

Cognizant Deal

Cognizant to buy TriZetto for $2.7 billion to boost healthcare business  Full Article 

India-Vietnam Ties

India-Vietnam Ties

India tightens Vietnam defence, oil ties ahead of China Xi's visit.  Full Article 

Antitrust Crusade

Antitrust Crusade

INSIGHT - "Mr. Confession" and his boss drive China's antitrust crusade .  Full Article 

Inflation Eases

Inflation Eases

Aug WPI inflation eases to near five-year low of 3.74 percent  Full Article 

Kashmir Floods

Kashmir Floods

Disease threatens as Kashmir flood waters turn fetid  Full Article 

Reuters India Mobile

Reuters India Mobile

Get the latest news on the go. Visit Reuters India on your mobile device.  Full Coverage